I hope my short article helps more people learn about this compound(Ethyl oxazole-5-carboxylate)Related Products of 118994-89-1. Apart from the compound(118994-89-1), you can read my other articles to know other related compounds.
The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: Ethyl oxazole-5-carboxylate( cas:118994-89-1 ) is researched.Related Products of 118994-89-1.Curreli, Francesca; Belov, Dmitry S.; Kwon, Young Do; Ramesh, Ranjith; Furimsky, Anna M.; O’Loughlin, Kathleen; Byrge, Patricia C.; Iyer, Lalitha V.; Mirsalis, Jon C.; Kurkin, Alexander V.; Altieri, Andrea; Debnath, Asim K. published the article 《Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120》 about this compound( cas:118994-89-1 ) in European Journal of Medicinal Chemistry. Keywords: phenyl pyrrole carboxamide preparation antiviral ADMET HIV1 gp120 structure; ADMET; Broad spectrum; ENV-pseudovirus; HIV-1; Structure-activity relationship (SAR); Virus entry antagonist; “CH(2)OH” switch hypothesis. Let’s learn more about this compound (cas:118994-89-1).
The authors are continuing the concerted effort to optimize the first lead entry antagonist, NBD-11021, which targets the Phe 43 cavity of the HIV-1 envelope glycoprotein gp120, to improve antiviral potency and ADMET properties. The authors present a structure-based approach that helped to generate working hypotheses to modify further a recently reported advanced lead entry antagonist, NBD-14107, which showed significant improvement in antiviral potency when tested in a single-cycle assay against a large panel of Env-pseudotyped viruses. The authors report the synthesis of twenty-nine new compounds and evaluation of their antiviral activity in a single-cycle and multi-cycle assay to derive a comprehensive structure-activity relationship (SAR). The authors have selected three inhibitors with the high selectivity index for testing against a large panel of 55 Env-pseudotyped viruses representing a diverse set of clin. isolates of different subtypes. The antiviral activity of one of these potent inhibitors, 55 (NBD-14189), against some clin. isolates was as low as 63 nM. The authors determined the sensitivity of CD4-binding site mutated-pseudoviruses to these inhibitors to confirm that they target HIV-1 gp120. Furthermore, the authors assessed their ADMET properties and compared them to the clin. candidate attachment inhibitor, BMS-626529. The ADMET data indicate that some of these new inhibitors have comparable ADMET properties to BMS-626529 and can be optimized further to potential clin. candidates.
I hope my short article helps more people learn about this compound(Ethyl oxazole-5-carboxylate)Related Products of 118994-89-1. Apart from the compound(118994-89-1), you can read my other articles to know other related compounds.
Reference:
Pyrazine – Wikipedia,
Pyrazine | C4H4N2 – PubChem